[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.5487/TR.2015.31.4.355

Effects of Styrene-metabolizing Enzyme Polymorphisms and Lifestyle Behaviors on Blood Styrene and Urinary Metabolite Levels in Workers Chronically Exposed to Styrene

Kim, Ki-Woong (Occupational Safety and Health Research Institute, KOSHA)

Publication Information

Toxicological Research / v.31, no.4, 2015 , pp. 355-361 More about this Journal

Abstract

The aim of this study was to investigate whether genetic polymorphisms of CYP2E1, GSTM1, and GSTT1 and lifestyle habits (smoking, drinking, and exercise) modulate the levels of urinary styrene metabolites such as mandelic acid (MA) and phenylglyoxylic acid (PGA) after occupational exposure to styrene. We recruited 79 male workers who had received chronic exposure in styrene fiberglass-reinforced plastic manufacturing factories. We found that serum albumin was significantly correlated with blood styrene/ambient styrene (BS/AS), urinary styrene (US)/AS, and US/BS ratios as well as urinary metabolites, that total protein correlated with US/MA and US/PGA ratios, and that low density lipoprotein (LDL)-cholesterol significantly correlated with US/BS, US/MA, and US/PGA ratios. Multiple logistic regression analyses using styrene-metabolizing enzyme genotypes and lifestyle habits as dependent variables and blood and urine styrene concentrations and urine styrene metabolite levels as independent variables revealed that $CYP2E1^*5$ was associated with the MA/US ratio and GSTM1 with US/BS, that a smoking habit was associated with US/AS and MA/US ratios and MA and PGA levels, and that regular exercise was correlated with PGA/US. In conclusion, the results suggested that genetic polymorphisms of styrene-metabolizing enzymes, lifestyle behaviors, and albumin and LDL-cholesterol serving as homeostasis factors together are involved in styrene metabolism.

Keywords

Styrene; Metabolism; Gene polymorphisms; Biological monitoring; Workers;

Citations & Related Records

Times Cited By KSCI : 1 (Citation Analysis)

Reference
Cited By KSCI

1	International Programme on Chemical Safety (IPCS). (1983) Styrene. Environmental Health Criteria 26. World Health Organization, Geneva, pp. 20-50.
2	Ministry of Employment and Labor (MoEL). (2013) 2013 Annual report for the health examination of workers. Ministry of Employment and Labor.
3	Watabe, T., Ozawa, N. and Yoshkawa, K. (1981) Stereochemistry in the oxidative metabolism of styrene by hepatic microsomes. Biochem. Pharmacol., 30, 1695-1698. DOI
4	Ohtsuji, H. and Ikeda, M. (1971) The metabolism of styrene in rat and the stimulatory effect of phenobarbital. Toxicol. Appl. Pharmacol., 18, 321-328. DOI
5	Laffon, B., Pasaro, E. and Mendez, J. (2001) Effects of styrene- 7,8-oxide over p53, p21, bcl-2 and bax expression in human lymphocyte cultures. Mutagenesis, 16, 127-132. DOI
6	Chakrabarti, S.K. (2000) Altered regulation of dopaminergic activity and impairment in motor function in rats after subchronic exposure to styrene. Pharmacol. Biochem. Behav., 66, 523-532. DOI
7	Husain, R., Srivastava, S.P., Mushtaq, M. and Seth, P.K. (1980) Effect of styrene on levels of serotonin, noradrenalin, dopamine and activity of acetyl cholinesterase and monoamine oxidase in rat brain. Toxicol. Lett., 7, 47-50. DOI
8	Sumner, S.J. and Fennell, T.R. (1994) Review of metabolic fate of styrene. Crit. Rev. Toxicol., 24, S11-33. DOI
9	American Conference of Government Industrial Hygienists (ACGIH). (2000) Threshold limit values (TLVs) for chemical substances and physical agents and biological exposure indices (BEIs). ACGIH, Cincinnati, OH.
10	Wenker, M.A., Kezic, S., Monster, A.C. and de Wolff, F.A. (2001) Metabolic capacity and interindividual variation in toxicokinetics of styrene in volunteers. Hum. Exp. Toxicol., 20, 221-228. DOI
11	De Palma, G., Manini, P., Mozzoni, P., Andreoli, R., Bergamaschi, E., Cavazzini, S., Franchini, I. and Mutti, A. (2001) Pholimorphism of xenobiotic-metabolizing enzymes and excretion of styrene-specific mercapturic acids. Chem. Res. Toxicol., 14, 1393-1400. DOI
12	Haufroid, V., Buchet, J.P., Gardinal, S., Ghittori, S., Imbriani, M., Hirvonen, A. and Lison, D. (2001) Importance of genetic polymorphism in interpreting drug-metabolizing enzymes for the interpretation of biomarkers of exposure of styrene. Biomarkers, 6, 236-249. DOI
13	Haufroid, V., Jakubowski, M., Janasik, B., Ligocka, D., Buchet, J.P., Bergamaschi, E., Manini, P., Mutti, A., Ghittori, S., Arand, M., Hangen, N., Oesch, F., Hirvonen, A. and Lison, D. (2002) Interest of genotyping and phenotyping of drugmetabolizing enzymes for the interpretation of biological monitoring of exposure to styrene. Pharmacogenetics, 12, 691-702. DOI
14	De Palma, G., Mozzoni, P., Scotti, E., Manini, P., Andreoli, R., Naccarati, A., Mercati, F., Migliore, L. and Mutti, A. (2003) [Genetic polymorphism of biotransforming enzymes and genotoxic effects of styrene]. G. Ital. Med. Lav. Ergon., 25 Suppl 3, 63-64.
15	Ma, M., Umemura, T., Mori, Y., Gong. Y., Saijo, Y., Sato, F., Kawai, T. and Kishi, R. (2005) Influence of genetic polymorphisms of styrene-metabolizing enzymes and smoking habits on levels of urinary metabolites after occupational exposure to styrene. Toxicol. Lett., 160, 84-91. DOI
16	Conccini, T., Di Nucci, A., Tonini, M., Maestri, L., Costa, L.G., Liuzzi, M. and Manzo, L. (1996) Effects of ethanol administration on cerebral non-protein sulfhydryl content in rats exposed to styrene vapour. Toxicology, 106, 115-122. DOI
17	NIOSH. (1996) NIOSH manual of analytical methods (4th edition). Method 1501, U.S. Department of Health and Human Services, Cincinnati.
18	Kim, K.W., Won, Y.L. and Ko, K.S. (2015) Ethnic differences in the metabolism of toluene: coparisons between Korean and foreign workers exposed to toluene. Toxicol. Res., 31, 25-32. DOI
19	de Carvalho, D., Lanchote, V.L., Bonato, P.S., Queiroz, R.H., Santos, A.C. and Dreossi, S.A. (1991) A new derivatization procedure for the analysis of hippuric acid and methyl hippuric acid by gaschromatography. Int. Arch. Occup. Environ. Health, 63, 33-37. DOI
20	Shaikh, R.S., Amir, M., Masood, A.I., Sohail, A., Athar, H.U., Siraj, S., Ali, M. and Anjam, M.S. (2010) Frequency distribution of GSTM1 and GSTT1 null allele in Parkistani population and risk of disease incidence. Environ. Toxicol. Pharmacol., 30, 76-79. DOI
21	Cai, L., Zheng, Z.L. and Zhang, Z.F. (2005) Cytochrome p4502E1 polymorphisms and the risk of gastric cardiac cancer. World J. Gastroenterol., 11, 1867-1871. DOI
22	Prieto-Castello, M.J., Cardona, A., Marhuenda, D., Roei, J.M. and Corno, A. (2010) Use of the CYP2E1 genotype and phenotype for the biological monitoring of occupational exposure to styrene. Toxicol. Lett., 192, 34-39. DOI
23	Kim, M.R. and Kim, C.W. (2007) Human blood plasma preparation for tow-dimensional gel electrophoresis. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 849, 203-210. DOI
24	Bern, M., Sand, K.M., Nilson, J., Sandlie, I. and Andersen, J.T. (2015) The role of albumin receptors in regulation of albumin homeostasis: Implications for drug delivery. J. Controlled Release, 211, 144-162. DOI
25	Carbonari, D., Mansi, A., Proietto, A.R., Paci, E., Bonanni, R.C., Gherardi, M., Gatto, M.P., Sisto, R. and Tranfo, G. (2015) Influence of genetic polymorphisms of styrene-metabolizing enzymes on the levels of urinary biomarkers of styrene exposure. Toxicol. Lett., 233, 156-162. DOI